| Application no. and date | 10188256.1 (espacenet) (Federated) (European Patent Register), 20060301 | | Patent/reg. no. and date | DK/EP 2281831, 20180418 | | Publication date | 20110209 | | Priority no. and date | GB 0504436, 20050303 | | EP pub. no. and date |
EP 2281831 20110209 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals S.A., Rue de l'Institut, 89
1330 Rixensart, BE | | Applicant ref. no. | 161522 | | Inventor | STEPHENNE, Jean, GlaxoSmithKline Biologicals S.A.
Rue De L'institut 89
1330 Rixensart, BE,
Hanon, Emmanuel Jules, GlaxoSmithKline Biologicals S.A.
Rue de l'Institut 89
1330 Rixensart, BE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/25 (2006.01) , A61K 39/39 (2006.01) , A61P 31/22 (2006.01) , C07K 14/04 (2006.01) | | Title | VARICELLA-ZOSTER VIRUS VACCINE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2018 00033 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
